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to the first-line treatment for OSA, continuous positive airway 
pressure (CPAP), though research in this area is limited. Stud-
ies comparing African American and white patients in the US 
are conflicting,17,21 but pilot data from our own NZ laboratory 
suggest that the significantly lower adherence rate in Māori, 
Pacific, and Asian groups compared with Europeans is still 
significant after controlling for socioeconomic status.22 In the 
US, greater adherence has been associated with higher socio-
economic status, using an area-based index.23 A recent Israeli 
study reported that patients with higher incomes were more 
likely to accept CPAP.24 Finally, more patients referred through 
a publicly funded clinic abandoned CPAP than privately fund-
ed patients in a Brazilian study.25 However, to our knowledge 
the aforementioned paper from our own laboratory is the only 
study that has found a significant contribution of ethnicity after 
controlling for socioeconomic status. Being retrospective, only 
one measure of socioeconomic status based on neighborhood 
of residence was available for this sample, and we suspect that 
after controlling for more specific measures, ethnicity may no 
longer be a significant independent predictor of adherence.
There are probably aspects of socioeconomic status in ad-
dition to the financial cost of treatment that have some bear-
ing on CPAP acceptance and adherence such as education, 
both in a broad sense as a patient’s level of education can 
strongly influence their healthcare management,26 and in a 
specific sense as a patient’s level of understanding of OSA 
and CPAP have been shown to affect adherence.27,28 Health 
INTRODUCTION
Obstructive sleep apnea (OSA) is a sleep related breathing 
disorder in which the upper airway is occluded repeatedly while 
asleep, and is associated with excessive daytime sleepiness,1 
neurocognitive decline,2 and the development of cardiovascu-
lar disease in the long term.3-5 Community-based prevalence 
studies in various locations including North America,6-8 South 
America,9 Spain,10 Korea,11 Hong Kong,12,13 India,14 Australia,15 
and New Zealand (NZ)16 have demonstrated that OSA is rea-
sonably common. Few studies have attempted to report ethnic 
differences in OSA prevalence within a community-based pop-
ulation. Studies comparing African American and white sub-
jects in the US,17,18 Japanese and white subjects in Brazil,19 and 
Māori and non-Māori subjects in NZ16,20 have found no signifi-
cant contribution of ethnicity to the prevalence and/or severity 
of OSA after controlling for measures of body habitus.
Beyond ethnic differences in disease prevalence and pre-
sentation, there may also be ethnic differences in adherence 
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Educational Package and Follow-Up Appointments
The education and follow-up support provided was the same 
for government- and privately-funded patients, apart from 
the aforementioned restrictions regarding machine and mask 
choice. All patients had received some verbal education re-
garding OSA and CPAP from their referring physician and a 
mailed brochure, and the technologist responsible for initiating 
treatment presented a standardized CPAP educational package 
during the first appointment (verbal introduction, diagrams, and 
video) designed to optimize adherence. A technologist phoned 
each patient after the first night of at-home treatment to trouble-
shoot any initial problems and encourage optimal usage, and 
patients were encouraged to attend half-hour follow-up ap-
pointments after 2 and 4 weeks. These appointments followed 
a standardized set of interview guidelines, available from the 
corresponding author. Objective adherence was downloaded 
from the data-card contained in each CPAP device during both 
follow-up appointments, and was recorded as the mean hours of 
use per 24-h period.
Questionnaires
Prior to receiving the educational package, patients were 
required to fill in 2 questionnaires and were provided with as 
much time to complete this task as was required. If it was nec-
essary for the questionnaire to be administered verbally by the 
technologist on duty, this was noted.
The first questionnaire was the Self-Efficacy Measure for 
Sleep Apnea (SEMSA), which measures 3 aspects of Bandura’s 
social cognitive model and has demonstrated internal consis-
tency of 0.92.38 The 3 SEMSA subscales are: risk perception 
(the patient’s perceived vulnerability to health risks), outcome 
expectancy (the patient’s perceived expectations regarding the 
potential of the behavior to reduce those risks), and treatment 
self-efficacy (the patient’s perceived ability to perform the be-
havior, that is, use CPAP effectively).38 Each subscale has a 
maximum score of 4, indicating high self-efficacy.
The second questionnaire was an in-house questionnaire 
including age, gender, ethnicity, languages spoken fluently, 
current level of employment, highest level of formal educa-
tion attained, individual gross annual income (all identical to 
questions contained in the 2006 NZ census), eligibility for a 
Community Services Card (issued by the NZ government to 
subsidize healthcare costs), and method of referral (govern-
ment- or privately funded). Prioritized ethnicity following NZ 
Ministry of Health guidelines was assigned when a patient indi-
cated multiple ethnic groups.39,40
Embedded in this questionnaire were the questions required 
for the Epworth Sleepiness Scale (ESS),41 NZ Deprivation 
Index (NZDep06),42 and NZ Individual Deprivation Index 
(NZiDep06).43 The ESS was also administered during both 
follow-up appointments. The NZDep06 is an index of socio-
economic deprivation based on data obtained in the most recent 
NZ census (2006), which divides the country into geographical 
mesh-blocks, each containing a median of 87 people. It is the 
only such measure available in New Zealand. Each mesh-block 
is assigned a number between 1 and 10 indicating the level of 
deprivation (10 = most deprived), accounting for income, home 
ownership, family support, employment, qualifications, living 
space, communication, and transport.42 The deciles are then rou-
literacy should also be considered as part of education as this 
can greatly affect a patient’s clinical care,29 but is a hitherto 
un-researched construct in CPAP adherence studies. Finally, 
as recently discussed in the literature,30 there is evidence from 
the aforementioned Israeli paper that there are ethnic differ-
ences in social support when beginning CPAP treatment.24 
The concept of self-efficacy—the extent to which a patient 
holds attitudes or beliefs that he or she is capable of attaining 
positive outcomes from treatment—is closely related to the 
amount of social support available, and has been found to be 
associated with CPAP adherence.31
Given the evidence that OSA is more prevalent in Māori 
than non-Māori in NZ and that Māori tend to present with more 
severe symptoms,16,32,33 there is a need to identify the reasons 
for poor CPAP adherence and use this knowledge to minimize 
ethnic disparities in CPAP usage, thereby reducing long-term 
risk of morbidity and mortality. Hence, we aimed to investigate 
adherence to treatment in a consecutive sample of NZ patients 
referred for CPAP, hypothesizing that ethnicity would not sig-
nificantly predict adherence after controlling for socioeconomic 
status, health literacy, and self-efficacy.
METHODS
Ethical approval was granted by the Central Region Ethics 
Committee (CEN/09/11/091), and all patients in the main anal-
yses gave written informed consent. Consent is not required 
to analyze and report routinely collected data as this is clas-
sified as an audit, so CPAP adherence and ethnicity data for 
non-consenting patients were able to be analyzed (discussed 
further below).
Recruitment of Patients and Diagnosis of OSA
All adult patients (≥ 25 years of age) living in the Greater 
Wellington region referred for CPAP treatment for the first time 
by respiratory/otolaryngology/cardiology physicians over a 
9-month period of 2010 were approached to take part in the 
study. There were no exclusion criteria. Apart from patients 
referred for split-night diagnostic/titration studies, all had un-
dergone a previous diagnostic sleep study of some description 
(Figure 1).
CPAP Initiation
Patients were established on CPAP during either a full-night 
or split-night manual titration following published clinical 
guidelines,34 or using an automatically adjusting positive air-
way pressure (auto-PAP) device (ResMed S8 Autoset II; NSW, 
Australia) for ≥ 7 nights at home using the mean 95th percentile 
pressure for ongoing CPAP use. All studies were performed and 
scored by experienced polysomnographic technologists accord-
ing to published criteria.35-37
All patients referred through the NZ government-funded 
health system were allocated a Fisher & Paykel (Auckland, NZ) 
HC608 device and a Fisher & Paykel mask. Patients funding 
their own treatment were able to choose from a range of Fisher 
& Paykel, Phillips Respironics (PA, USA), or ResMed devices 
and masks. Government-funded patients did not contribute fi-
nancially to their diagnosis or treatment; private patients were 
required to pay full costs for their physician appointment/s, di-
agnosis, titration, CPAP device, and mask.
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the first follow-up appointment, by one of two authors (JPB or 
KMO). This short reading-recognition test requires the patient 
to correctly pronounce 66 medical-related words. A raw score 
is obtained by adding the number of correct responses; this can 
be categorized to an estimate of the US school grade reading 
level if necessary.
Statistical Analysis
All data were double-entered before statistical analysis, 
performed using SPSS (Version 18.0; NY, USA). Missing 
data were excluded pairwise for all analyses. Continuous data 
were analyzed for normality of distribution and homogeneity 
tinely combined into quintiles for data analysis. The NZDep06 
can be calculated based only on a patient’s residential address. 
The NZiDep06 must be collected prospectively and includes 8 
dichotomous questions targeting high levels of deprivation.43
All questionnaires were scored by author JPB, follow-
ing published guidelines for the ethnicity, NZ census, ESS, 
NZDep06, and NZiDep06 questions, and instructions provided 
by the authors of the SEMSA.
Health Literacy Test
The Rapid Estimate of Adult Literacy in Medicine (REALM)44 
was administered and scored in a standardized manner during 
Figure 1—Flowchart of diagnostic and treatment pathways. *Used Compumedics (Victoria, Australia) Somte PSG with Nonin oximeter. #Used Compumedics 
Somte with Nonin oximeter. §Used Compumedics (Victoria, Australia) Grael with Masimo (CA, USA) Rad 7 oximeter. OSA, obstructive sleep apnea; CPAP, 
continuous positive airway pressure; auto-PAP, automatically adjusting positive airway pressure.
Family doctor
Diagnosis
Treatment
Follow-Up
Physician 
(government-funded 
n = 158, 81.4%; 
privately-funded 
n = 36, 18.6%)
Full night home-based 
level II* (n = 28) or III# 
(n = 2) diagnostic study
Full night lab-based 
level I diagnostic 
study§ (n = 8)
Sleep Clinic (n = 194) n = 32 did not consent
Split-night lab-based 
diagnostic & manual 
titration§ followed by 
CPAP (n = 124)
n = 27 n = 2n = 6 n = 3
1 week home-based 
Auto-PAP followed by 
CPAP (n = 33)
Full night lab-based 
manual titration followed 
by CPAP (n = 5)
n = 32 did not 
demonstrate 
OSA
n = 3 declined 
CPAP
n = 1 lost to 
follow-up
2-week follow-up appointment (government-funded n = 101, 80.2%; privately-funded n = 25, 19.8%)
4-week follow-up appointment (government-funded n = 101, 80.2%; privately-funded n = 25, 19.8%)
OSA confirmed; CPAP required
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Māori fluently in addition to English. Ten 
of the 126 patients (7.9%) required that the 
questionnaires be administered verbally; 
9 of these were administered by the tech-
nologist on duty, and the remaining was 
administered by the patient’s translator.
Missing Data
Eleven patients did not know whether 
they were eligible for a Community Servic-
es Card. Two patients did not indicate their 
education level; 5 patients did not indicate 
their income level. Two, 3 and 9 patients 
did not complete the SEMSA subscales 
risk perception, outcome expectancies, and 
treatment self-efficacy, respectively. Seven 
patients refused to complete the REALM.
Ethnicity, CPAP Adherence, and 
Socioeconomic Status
Average CPAP adherence for all con-
senting patients was non-normally distrib-
uted around a median of 5.63 h/night (interquartile range [IQR] 
2.55). This was not significantly different from the 32 patients 
who did not consent to the study (U = 1756.5, P = 0.26), in-
cluding 13 Europeans (41%), 9 Māori (28%), 4 Pacific (12%), 
6 Asian (19%), and 0 “other” patients.
All further analyses used data from consenting patients only. 
There was no significant difference in adherence between the 
5 ethnic groups (median adherence 5.77, 5.11, 5.44, 5.17, and 
6.41 h/night in Europeans, Māori, Pacific, Asian, and other 
groups, respectively; H(4) = 4.02 P = 0.20); however, Māori 
used CPAP significantly less than non-Māori (median 5.11 
IQR 2.24 and 5.71 IQR 2.61 h/night, respectively; U = 996.0, 
P = 0.05). Māori were significantly overrepresented in areas 
of high socioeconomic deprivation (NZDep06) compared 
with non-Māori (χ2(4) = 7.56, P = 0.05); however, there was 
no significant difference between Māori and non-Māori across 
NZiDep06 categories (χ2(4) = 3.08, P = 0.28) (Figure 2).
There was a significant relationship between the NZDep06 
and NZiDep06 data (χ2(4) = 25.99, P = 0.03), indicating that 
patients reporting high individual deprivation tended to live in 
neighborhoods of high deprivation, and vice versa. Adherence 
did not differ significantly between the 5 area-based NZDep06 
categories (H(4) = 4.11, P = 0.20), though there was a signifi-
cant difference in adherence between patients in the 5 individu-
al NZiDep06 categories (H(4) = 10.42, P = 0.02), with a drop in 
adherence occurring at quintile 5 (lowest socioeconomic status) 
compared with higher socioeconomic status quintiles (Figure 
3). There were no significant relationships between adherence 
and the REALM raw score, which reached the maximum pos-
sible for 23% of patients (r
s
 = 0.06, P = 0.54), or the 3 SEM-
SA subscales (risk perception r
s
 = −0.06, P = 0.51, outcome 
expectancies r
s
 = −0.04, P = 0.68, and treatment self-efficacy 
r
s
 = 0.05, P = 0.63).
Predictive Models
Table 2 shows the univariate relationships between adher-
ence (categorized as < / ≥ 4 h/night) and the hypothesized pre-
of variance. Five-group ethnic and socioeconomic compari-
sons were performed using Kruskal-Wallis tests; two-group 
ethnic comparisons were performed using Mann-Whitney 
tests, independent-samples t-tests, or Pearson χ2 tests. Uni-
variate and multivariate logistic regression forced-entry 
models were used to assess the ability of hypothesized vari-
ables to predict CPAP adherence as a dichotomous outcome. 
Multicollinearity between predictors was investigated by in-
specting variance inflation factors and eigenvalues, as well as 
simple Pearson correlations. Standardized residuals were in-
spected to identify potential outliers. All statistical tests were 
considered significant when P ≤ 0.05. More details regarding 
the study procedure and analyses are available from the cor-
responding author.
RESULTS
Sample Description
Over the 9-month study period, 194 patients were referred 
for CPAP treatment that met inclusion criteria. Thirty-two 
were not titrated, as no OSA was demonstrated during the di-
agnostic period of the split-night study; 3 declined CPAP fol-
lowing a successful titration. Of the 159 patients remaining, 
127 consented to the study (recruitment rate 80%); 80.3% of 
the cohort was referred through the government-funded health 
system. Adherence data were unavailable for one Māori pa-
tient who failed to attend follow-up appointments; the final 
dataset therefore comprised 79 Europeans (62.2%), 25 Māori 
(19.7%), 14 Pacific (11.0%), 6 Asian (4.7%), and 2 “other” 
ethnicity (1.6%). Table 1 summarizes the study sample com-
paring Māori and non-Māori; the Māori patients were signifi-
cantly younger with a higher average BMI than the non-Māori 
patients (both P < 0.01).
All patients except one spoke English fluently; this patient 
(Pacific) spoke only Samoan and brought a translator to all ap-
pointments. A further 9 Pacific patients spoke one of the Pacific 
languages fluently in addition to English; 9 Māori patients spoke 
Table 1—Descriptive comparison of Māori and non-Māori patients
Māori (n = 25)
Mean ± SD
Non-Māori (n = 101)
Mean ± SD
P-value 
(2-sided)
Age (years) 45.0 ± 11.4 52.5 ± 11.7 < 0.01
Number of males 21 (80.8%) 79 (79%) 0.86
BMI (kg/m2) 43.4 ± 9.6 37.1 ± 9.0 < 0.01
Baseline ESS (/24) 14.7 ± 5.9 12.6 ± 5.3 0.09
Diagnostic sleep efficiency (%) 77.0 ± 17.9 76.9 ± 14.4 0.61
Diagnostic AHI (events/h) 63.6 ± 35.1 56.3 ± 39.7 0.22
Therapeutic CPAP (cm H2O) 12.0 ± 3.6 10.9 ± 3.0 0.24
CPAP trial length (days) 34.5 ± 14.5 31.4 ± 14.4 0.30
SEMSA: Risk perception (/4) 2.70 ± 0.56 2.80 ± 0.54 0.41
SEMSA: Outcome expectancies (/4) 3.17 ± 0.54 3.22 ± 0.53 0.89
SEMSA: Treatment self-efficacy (/4) 3.23 ± 0.57 3.25 ± 0.49 0.96
REALM raw score (/66) 61.02 ± 10.60 59.50 ± 13.36 0.36
BMI, body mass index; ESS, Epworth Sleepiness Scale; AHI, apnea-hypopnea index; CPAP, 
continuous positive airway pressure; SD, standard deviation; SEMSA, Self Efficacy Measure for 
Sleep Apnea; REALM, Rapid Estimate of Adult Literacy in Medicine.
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dictor variables. It was decided a priori to identify 4 
predictors in addition to ethnicity (which showed a 
significant between-group difference) to enter into a 
multiple logistic regression model as a conservative 
estimate based on our sample size of 126. Eligibility 
for a Community Services Card, NZiDep06 quin-
tiles and annual income were added to the model 
(all univariate P < 0.05) as well as education, which 
approached significance (P = 0.06). Table 3 shows 
the independent significance of each predictor. 
There was no significant evidence of multicollinear-
ity between predictors, and when one outlier was 
removed (standardized residual ≥ 3.0) this did not 
change the results of the model therefore this patient 
was retained. Overall, the model had a Nagelkerke 
pseudo-R2 of 0.23 (χ2(9) = 17.54, P = 0.04), and 
thus explains approximately 23% of the variability 
in CPAP adherence.
DISCUSSION
In a sample of 126 CPAP-naïve patients in NZ, 
this study found that Māori used CPAP significantly 
less than non-Māori over an average follow-up pe-
riod of 33 days (median difference of 0:36 hours). 
A multiple regression model including ethnicity, 
socioeconomic status assessed individually, annual 
income, level of formal education, and eligibil-
ity for government-subsidized healthcare explained 
23% of the total variance in adherence, with only 
non-completion of tertiary education and high indi-
vidual socioeconomic deprivation remaining as sig-
nificant independent predictors of CPAP adherence 
not reaching ≥ 4 h/night (odds ratios 0.25 and 0.10, 
respectively), supporting our original hypothesis. 
Other research studies investigating adherence to 
CPAP have reported similarly low explanatory pow-
er (for example, 24% in a model including psycho-
logical constructs, ESS, BMI, AHI, and pressure45), 
indicating that a large variety of variables are likely 
to be important contributors.
Although in our sample the area-based NZDep06 
did not significantly predict CPAP adherence, the 
individual NZiDep06 was both a univariate and 
multivariate predictor of average adherence ≥ 4 h. 
By aggregating and averaging both personal mea-
sures (such as income, employment, and education) 
as well as area-based measures (such as access to 
transport and communication infrastructure), the 
NZDep06 is not as specific as the NZiDep06, which 
may partially explain the lack of association be-
tween the NZDep06 and CPAP adherence. Further, 
while the NZiDep06 was a significant predictor of 
adherence, individual domains encompassed by this 
questionnaire (income, employment, eligibility for 
Community Services Card, and referral type) were 
not. We believe that this apparent discrepancy can 
be explained by the fact that the NZiDep06 was de-
signed to target very high levels of deprivation, and 
as shown in Figure 2, the drop in adherence occurs 
Table 2—Univariate predictors of average CPAP adherence ≥ 4 h/night
Predictors
% with adherence 
≥ 4 hours OR (95% CI) P-value
Ethnicity
Non-Māori* 79.2
Māori 73.1 0.83 (0.30-2.34) 0.73
Age (years)
< 40 73.7 0.77 (0.21-0.28) 0.69
40-49* 78.4
50-59 70.5 0.80 (0.28-0.27) 0.68
≥ 60 88.9 2.21 (0.53-9.25) 0.28
Gender
Male* 78.2
Female 76.9 1.11 (0.38-3.31) 0.85
Treatment type
Laboratory titration* 78.7
Auto-PAP titration 96.2 0.80 (0.31-2.06) 0.65
Baseline ESS (/24 points)
< 11 81.8 1.36 (0.54-3.41) 0.52
≥ 11* 75.9
Change in ESS over trial (/|24| points)
Improvement ≥ 10 points 87.5 2.49 (0.76-8.21) 0.13
Improvement < 10 points* 73.8
No change/Deterioration 87.0 2.37 (0.62-9.06) 0.21
Diagnostic sleep efficiency (%)
< 70 74.2 0.96 (0.34-2.70) 0.94
70-84.9* 73.5
≥ 85 84.4 1.81 (0.64-5.11) 0.26
Diagnostic AHI (events/h)
< 15 (mild OSA) 62.5 0.41 (0.13-1.27) 0.82
15-29.9 (moderate OSA) 82.6 1.15 (0.35-3.84) 0.12
≥ 30 (severe OSA)* 79.5
Therapeutic pressure (cm H2O)
< 10 81.1 1.42 (0.50-4.03) 0.52
10.0-13.9 * 77.9
≥ 14 71.4 0.71 (0.23-2.14) 0.54
SEMSA: Risk perception (/4 points)
< 2.5 75.0 1.54 (0.59-4.01) 0.38
≥ 2.5* 82.9
SEMSA: Outcome expectancies (/4 points)
< 2.5 76.1 1.96 (0.41-9.27) 0.38
≥ 2.5* 86.7
SEMSA: Treatment self-efficacy (/4 points)
< 2.5 78.8 0.94 (0.24-3.67) 0.93
≥ 2.5* 78.6
*indicates the reference category (chosen due to majority). Auto-PAP, automatically 
adjusting positive airway pressure; CI, confidence interval; ESS, Epworth Sleepiness 
Scale; OR, odds ratio; SEMSA, Self Efficacy Measure for Sleep Apnea; REALM, Rapid 
Estimate of Adult Literacy in Medicine. Odds ratio < 1.0 indicates adherence < 4 h/
night. REALM categories defined according to published criteria44; SEMSA categories 
defined according to averages published previously.38 A Community Services Card 
is provided by New Zealand government to subsidize healthcare costs. NZDep06 is 
an area-based measure of socioeconomic deprivation based on 8 variables collected 
in the 2006 census.42 NZiDep06 is an individual questionnaire targeting high levels of 
socioeconomic deprivation.43 Numbers in bold type P ≤ 0.05.
Table 2 continues on the following page
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patients established on CPAP over a 10-month pe-
riod of 2008 without seeking consent, whereas the 
current prospective study required informed con-
sent, and it seems feasible to hypothesize that pa-
tients who did not consent were those more likely 
to exhibit lower adherence. However, we did not 
find a significant difference in CPAP adherence be-
tween the consenting and non-consenting patients; 
although the minority groups were more likely not 
to give consent, almost half of the non-consenting 
patients were European. We therefore suggest that 
the discrepancy in results between this study and the 
pilot was due in part to the sample size being sub-
stantially smaller (n = 127 compared with n = 214), 
as well as the sleep technologists being aware of 
the pilot data before commencement of the current 
study. Although efforts were made to standardize 
patient care, it is possible that staff gave augment-
ed follow-up support to patients of non-European 
ethnicity, given their knowledge that these patients 
were more likely to exhibit lower adherence, result-
ing in increased adherence of these groups compar-
ing 2008 and 2010 data.
In finding that referral type (government- or pri-
vately funded) did not significantly predict adher-
ence to CPAP, our results are also in contrast to the 
aforementioned Brazilian paper, which reported 
that publicly funded patients were more likely than 
privately funded patients to abandon CPAP use.25 
Although this conclusion could be explained by 
considering that patients funding their own treat-
ment at considerable personal expense have a 
higher incentive to use treatment, it could also be 
reasonably hypothesized that the knowledge of high 
ongoing costs associated with treatment could also 
be a financial disincentive among these patients. 
Minimal research has addressed this issue, which 
requires clarification in further studies.
Health literacy and self-efficacy were not signifi-
cant univariate predictors of adherence in this co-
hort. A ceiling effect was evident when examining 
the REALM raw scores; research has shown slight-
ly higher levels of literacy in the NZ population 
compared with the US46 where the REALM was 
developed and validated, and it is therefore possible 
that an alternative measure of health literacy more 
appropriate for a NZ sample may be a useful predic-
tor of adherence by giving a larger spread of data. 
The 3 SEMSA subscales had wide scatter reflected in r
s
 correla-
tions with adherence of < 0.1. However, an article published 
after the current study was designed reported that the SEMSA 
taken post-education and after one week of treatment, though 
not at baseline, was significantly associated with adherence,47 
suggesting that perhaps we administered this questionnaire too 
early in the protocol. However, we were attempting to locate 
baseline variables predictive of adherence in order to design a 
targeted intervention before beginning treatment.
The major limitation of this study was the reasonably small 
sample size, which allowed for only four predictors of CPAP 
in the patients of quintile 5 (highest level of deprivation) com-
pared with the patients reporting lower levels of deprivation. 
Based on these data, we therefore conclude that socioeconomic 
status is only an important contributor to CPAP adherence when 
deprivation levels are very high.
These data are in contrast with our retrospective pilot study, 
which found a significant difference in adherence comparing 
Māori, Pacific, European, and Asian groups that persisted af-
ter controlling for area-based socioeconomic status, with be-
tween-group differences in adherence of up to one hour.22 This 
retrospective audit was ethically able to include data from all 
Predictors
% with adherence 
≥ 4 hours OR (95% CI) P-value
Referral type
Government health system* 80.4
Privately funded 68.0 0.49 (0.19-1.31) 0.16
Community Services Card
No* 82.8
Yes 62.1 0.38 (0.15-0.97) 0.04
Health literacy: REALM
≥ high school grade* 83.5
< high school grade 69.6 0.45 (0.16-1.23) 0.13
Education
Primary/secondary education 71.2 0.41 (0.16-1.03) 0.06
Tertiary education* 86.4
NZDep06 (quintile)
1 (low deprivation)* 77.5
2 88.9 2.32 (0.45-12.05) 0.32
3 60.0 0.50 (0.15-1.64) 0.25
4 76.0 0.92 (0.28-2.99) 0.89
5 (high deprivation) 87.5 2.03 (0.49-8.40) 0.33
NZiDep06 (quintile)
1 (low deprivation)* 84.8
2 84.2 0.95 (0.23-3.88) 0.95
3 66.7 0.36 (0.11-1.17) 0.09
4 76.9 0.89 (0.17-4.70) 0.89
5 (high deprivation) 45.5 0.15 (0.04-0.58) 0.01
Annual income (NZ dollars)
< $20,000 57.7 0.26 (0.08-0.82) 0.02
≥ $20,000 < $60,000* 85.1
≥ 60,000 83.7 0.90 (0.30-2.71) 0.85
Employment
Full time* 82.7
Part time 85.7 1.25 (0.14-11.25) 0.84
Unemployed 66.7 0.45 (0.19-1.11) 0.08
*indicates the reference category (chosen due to majority). Auto-PAP, automatically 
adjusting positive airway pressure; CI, confidence interval; ESS, Epworth Sleepiness 
Scale; OR, odds ratio; SEMSA, Self Efficacy Measure for Sleep Apnea; REALM, Rapid 
Estimate of Adult Literacy in Medicine. Odds ratio < 1.0 indicates adherence < 4 h/
night. REALM categories defined according to published criteria44; SEMSA categories 
defined according to averages published previously.38 A Community Services Card 
is provided by New Zealand government to subsidize healthcare costs. NZDep06 is 
an area-based measure of socioeconomic deprivation based on 8 variables collected 
in the 2006 census.42 NZiDep06 is an individual questionnaire targeting high levels of 
socioeconomic deprivation.43 Numbers in bold type P ≤ 0.05.
Table 2 (continued)—Univariate predictors of average CPAP adherence ≥ 4 h/night
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The measure of CPAP usage adopted in this study (hours per 
night averaged over a one-month period) is a simplified metric, 
and further ethnic and/or socioeconomic differences may have 
been apparent in measures such as number of nights with > 4 
h usage, or number of missed nights. Although research sug-
gests that long-term adherence patterns are established within 
the first few days of treatment,21 greater insight would have 
been gained by regularly downloading adherence over a time 
period of one year or more. Other limitations include the use 
of inappropriate measures of health literacy and self-efficacy, 
which does not allow us to rule out the potentially important 
contributions of these concepts to CPAP adherence, the absence 
of either inter-rater or intra-rater reliability data for the REALM 
scoring which is potentially open to bias, and the absence of a 
adherence in addition to ethnicity to be added to a multiple re-
gression model. However, it should be noted that this sample 
of 126 represents 80% of consecutive patients established on 
CPAP over a nine-month period in one of the largest sleep 
clinics in NZ, which has a catchment population of just under 
400,000, representing approximately 10% of the total popula-
tion of NZ. The sample sizes of the Māori and non-Māori groups 
were not even, due to the consecutive approach to recruitment. 
Figure 3—A comparison of mean CPAP adherence in each of the 5 
individual socioeconomic (NZiDep06) categories (H(4) = 10.42, P = 0.02).
*Denotes post hoc comparisons. Outliers are those which lie > 1.5 
interquartile ranges below the lower quartile.
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Table 3—Independent predictors of average CPAP adherence ≥ 4 h/night
Predictors OR (95% CI) P-value
Ethnicity
Non-Māori*
Māori 2.35 (0.51-10.73) 0.27
Education
Primary/secondary education 0.25 (0.08-0.83) 0.02
Tertiary education*
NZiDep06 quintile (1 = low deprivation)
1 (low deprivation)*
2 1.03 (0.22-4.94) 0.97
3 0.45 (0.09-2.35) 0.34
4 0.92 (0.14-6.15) 0.93
5 (high deprivation) 0.10 (0.02-0.86) 0.04
Annual income (NZ dollars)
 < $20,000 0.24 (0.04-1.64) 0.14
 ≥ $20,000 < $60,000*
 ≥ 60,000 0.65 (0.16-2.61) 0.54
Community Services Card
No*
Yes 1.87 (0.25-13.9) 0.54
*indicates the reference category (chosen due to majority). CI, confidence 
interval; OR; odds ratio. Odds ratio < 1.0 indicates adherence < 4 h/night. 
A Community Services Card is provided by New Zealand government 
to subsidize healthcare costs. NZiDep06 is an individual questionnaire 
targeting high levels of socioeconomic deprivation.43 Numbers in bold 
type P ≤ 0.05.
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variety of ethnic backgrounds. If successful, such an interven-
tion could conceivably be modified for use in other countries 
and disease states.
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